IL6 and cancer: The decrease in IL-6 secretion by the adipocytes upon inhibition of SHP2, PDHA1 or ROS also suggests that the SHP2-PDHA1-ROS axis might regulate inflammation in the adipose tissue, and thereby indirectly influences cancer progression.